Sensorion Presents SENS-401 Data at ARO 2018 MidWinter Meeting

SENS-401, R-azasetron besylate, is a drug candidate that aims to protect and preserve inner ear tissue when lesions are present that can cause progressive or sequelar hearing impediments.